Miura S,Koh Y, Azuma K, Yoshioka H, Koyama K, Teraoka S,Ishii H, Kibata K,Ozawa Y, Tokito T, Oyanagi J,Shimokawa T, Kurata T, Yamamoto N, Tanaka H: Afatinib plus osimertinib in the treatment of osimertinib-resistant non-small cell lung carcinoma: a phase I clinical trial. BMC Cancer 23: doi: 10.1186/s128855-022-10467-W.,2023.
Ogasawara T, Tajima Y, Nakamura N, Kanasaki H, Matsuyama W, Niwa M, Ozawa Y, Sugiura M, Ogiku M,Sato J: The effect of l-hydroxy-Vitamin D treatment in hospitalized patients with COVID-19:A retrospective study. Clinical Nutrition 42: 2045-50, 2023.
Rudin CM, Liu SV, Soo RA, Lu S, Hong MH, LeeJS,Bryl M, Dumoulin DW, Rittmeyer A, Chiu CH, Ozyilkan 0, Johnson M, Navarro A, Novello S, Ozawa Y,Tam SH, Patil NS, Wen X, Huang M, Hoang T, Meng R, Reck M: SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer.J Clin Oncol.doi: 10.1200/JCO.23.01363,2023.
Takase E, Akamatsu H, Teraoka S, Nakaguchi K, Tanaka M, Kaki T, Furuta K, Sato K, Murakami E, Sugimoto T, Shibaki R, Fujimoto D, Hayata A, Tokudome N,Ozawa Y, Koh Y, Nakanishi M, Kanai K, Shimokawa T, Yamamoto N: A phase II study of High-Flow Nasal Cannula as palliative care in advanced cancer patients. Journal of Pain and Symptom Management.(in press)